These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Serum cationic trypsinogen: marker of exocrine pancreatic dysfunction in children with protein-calorie malnutrition]. de Kolster CC; Kolster JG; Rached I; Estopiñán M; Azuaje M; Bordones G; Castro J; Carvajal A; Laurentin N G E N; 1991; 45(2):92-7. PubMed ID: 1843944 [TBL] [Abstract][Full Text] [Related]
3. Age-related alterations in immunoreactive pancreatic lipase and cationic trypsinogen in young children with cystic fibrosis. Cleghorn G; Benjamin L; Corey M; Forstner G; Dati F; Durie P J Pediatr; 1985 Sep; 107(3):377-81. PubMed ID: 4032133 [TBL] [Abstract][Full Text] [Related]
4. Abnormalities of circulating immunoreactive pancreatic anionic trypsinogen in cystic fibrosis: an assay artifact due to cross-reacting serum antibodies. Moore DJ; Largman C; Kopelman HR; Wong S; Durie PR Clin Biochem; 1986 Oct; 19(5):303-7. PubMed ID: 3769196 [TBL] [Abstract][Full Text] [Related]
6. Plasma immunoreactive pancreatic cationic trypsinogen in cystic fibrosis: a sensitive indicator of exocrine pancreatic dysfunction. Durie PR; Largman C; Brodrick JW; Johnson JH; Gaskin KJ; Forstner GG; Geokas MC Pediatr Res; 1981 Oct; 15(10):1351-5. PubMed ID: 7301457 [TBL] [Abstract][Full Text] [Related]
7. Serum immunoreactive pancreatic lipase and cationic trypsinogen for the assessment of exocrine pancreatic function in older patients with cystic fibrosis. Cleghorn G; Benjamin L; Corey M; Forstner G; Dati F; Durie P Pediatrics; 1986 Mar; 77(3):301-6. PubMed ID: 3951910 [TBL] [Abstract][Full Text] [Related]
8. Serum immunoreactive cationic trypsinogen: a useful indicator of severe exocrine dysfunction in the paediatric patient without cystic fibrosis. Moore DJ; Forstner GG; Largman C; Cleghorn GJ; Wong SS; Durie PR Gut; 1986 Nov; 27(11):1362-8. PubMed ID: 3792918 [TBL] [Abstract][Full Text] [Related]
9. Age-related alterations of immunoreactive pancreatic cationic trypsinogen in sera from cystic fibrosis patients with and without pancreatic insufficiency. Durie PR; Forstner GG; Gaskin KJ; Moore DJ; Cleghorn GJ; Wong SS; Corey ML Pediatr Res; 1986 Mar; 20(3):209-13. PubMed ID: 3703609 [TBL] [Abstract][Full Text] [Related]
10. Longitudinal evaluation of serum trypsinogen measurement in pancreatic-insufficient and pancreatic-sufficient patients with cystic fibrosis. Couper RT; Corey M; Durie PR; Forstner GG; Moore DJ J Pediatr; 1995 Sep; 127(3):408-13. PubMed ID: 7658271 [TBL] [Abstract][Full Text] [Related]
11. Determination of human pancreatic cationic trypsinogen in serum by radioimmunoassay. Geokas MC; Largman C; Brodrick JW; Johnson JH Am J Physiol; 1979 Jan; 236(1):E77-83. PubMed ID: 434151 [TBL] [Abstract][Full Text] [Related]
12. Diagnostic accuracy of serum cationic trypsinogen estimation for pancreatic diseases. Masoero G; Andriulli A; Bianco A; Benitti V; Marchetto M; De La Pierre M Dig Dis Sci; 1982 Dec; 27(12):1089-94. PubMed ID: 7172958 [TBL] [Abstract][Full Text] [Related]
13. Low serum trypsinogen levels in chronic pancreatitis: Correlation with parenchymal loss, exocrine pancreatic insufficiency, and diabetes but not CT-based cambridge severity scores for fibrosis. Zhan W; Akshintala V; Greer PJ; Greer JB; Alkaade S; Anderson MA; Muniraj T; Papachristou GI; Sandhu BS; Slivka A; Wilcox CM; Bellin MD; Singh VK; Yadav D; Brand RE; Whitcomb DC; Pancreatology; 2020 Oct; 20(7):1368-1378. PubMed ID: 32967795 [TBL] [Abstract][Full Text] [Related]
14. The ontogeny of serum immunoreactive pancreatic lipase and cationic trypsinogen in the premature human infant. Cleghorn G; Durie P; Benjamin L; Dati F Biol Neonate; 1988; 53(1):10-6. PubMed ID: 3355866 [TBL] [Abstract][Full Text] [Related]